Vega Stem Cell, a leading provider of advanced regenerative therapies in Thailand, proudly served as a co-host of the International Cell & Tissue Conference (ICTC) a distinguished global gathering of researchers, clinicians, and innovators in the field of stem cell and tissue-based medicine. The event aligns closely with Vega Stem Cell’s Center of Excellence initiative and marks a significant step in Thailand’s growing reputation as a center for safe, effective, and ethically driven stem cell therapy.
Hosted in Bangkok, the ICTC brought together a full day of scientific presentations, clinical insights, and international collaboration highlighting the fast-paced advancements and wide-reaching potential of cell and tissue technologies in both human and veterinary medicine.
A Global Platform for Innovation in Stem Cell Therapy
The event began with opening remarks from Dr. Chutima Eamchotchawalit, governor of the Thailand Institute of Scientific and Technological Research (TISTR), who emphasized the importance of science-led collaboration in strengthening Thailand’s growing biomedical sector.
Associate Professor Too Heng Phon from the National University of Singapore then delivered the keynote address, sharing valuable insights on non-viral, precision-engineered mesenchymal stem cells (MSCs). His presentation traced the development of these advanced therapies from lab-based innovation to clinical application, highlighting how modern stem cell technologies are becoming increasingly safe, accurate, and clinically accessible.
Stem Cell Treatments for Humans and Animals
One of the key moments of the event came from Dr. Ruttachuk Rungsiwiwutt, assistant professor at Srinakharinwirot University, who presented pioneering research on the use of mesenchymal stem cell therapy in animals. His work showcased how stem cells are being applied to manage joint degeneration and long-term illnesses in pets, reflecting similar therapeutic outcomes observed in human medicine.
The session highlighted the growing significance of regenerative medicine in veterinary practice, illustrating the wide-reaching potential of stem cell therapy across different species.
Exploring the Future: CRISPR, CAR-T, and AI in Stem Cell Research
The afternoon sessions explored some of the most advanced areas in biomedical research:
- Jungjoon Kempthorne Lee discussed the application of extra-seq technology to identify off-target effects in CRISPR-edited human stem cells, a crucial process for ensuring the safety and effectiveness of gene-editing therapies.
- Sun Hongyan from GemPharmaTech provided insights into CAR-T cell therapy, emphasizing non-clinical testing methods designed to meet challenges in treating complex diseases such as cancer.
- Jennifer Dodgson of Kipley AI in Singapore presented a forward-thinking talk on the role of artificial intelligence in regenerative medicine, explaining how AI can speed up research, tailor stem cell therapies to individual patients, and support better clinical decision-making.
Thailand’s Strategic Role in Medical Tourism and Regenerative Investment
The conference also highlighted Thailand’s status as a premier destination for medical tourism, especially in the field of stem cell therapy. Dr. Gary Lim, an expert in naturopathic medicine, led a session that focused on the country’s advanced clinical facilities, cost advantages, and its growing reputation for safety and innovation in regenerative healthcare.
With increased investment, a skilled workforce, and supportive policies, Thailand is well positioned to become a leader in Asia’s emerging biotech and cell therapy industries.
Vega Stem Cell: A Center of Excellence for Stem Cell Treatments in Thailand
As a cohost of the ICTC, Vega Stem Cell reaffirmed its commitment to providing world-class stem cell therapies through its Center of Excellence. This initiative encompasses:
- the use of advanced protocols with high-quality, ethically sourced mesenchymal stem cells
- personalized treatments for orthopedic, metabolic, autoimmune, and anti-aging conditions
- ongoing partnerships with international institutions and researchers
- organizing educational and scientific events to raise standards of care across Asia
With a strong focus on clinical excellence, patient safety, and scientific integrity, Vega Stem Cell continues to drive Thailand’s emergence as a leading global hub for regenerative medicine.
About Vega Stem Cell
Vega Stem Cell is a reputable provider of stem cell therapy in Thailand, delivering advanced regenerative treatments for patients looking for natural, science-supported alternatives to traditional medicine. Specializing in mesenchymal stem cells, the clinic offers customized therapies aimed at promoting healing, revitalization, and lasting health.
By combining clinical expertise, ethical practices, and international collaboration, Vega Stem Cell is dedicated to advancing the frontiers of cell-based therapies.
Contact Information
Vega Medical Services
3/6, The Primary 101, Soi Lad Phrao 101
Lad Phrao Road, Khlong Chan
Bang Kapi District, Bangkok 10240
Thailand
Email: vegastemcell@gmail.com
Tel & WhatsApp: +66 (0) 86 691 6915
Website: www.vegastemcell.com